We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Catalyst Biosciences and Centocor R&D Form Collaboration to Discover and Develop Engineered Protease Therapeutics

News   Jan 08, 2008

 
Catalyst Biosciences and Centocor R&D Form Collaboration to Discover and Develop Engineered Protease Therapeutics
 
 
 

RELATED ARTICLES

Modified Form of Botox Could Replace Opioids as Treatment for Chronic Pain

News

A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.

READ MORE

Key Ingredient in Diabetes Drug Modified to Improve Side Effects

News

Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.

READ MORE

Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein Target

News

A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE